Ep. 133: Nina Deka: Healthcare Technology Still In Early Stages Of Disruption
Investing With IBD
00:00
A New Therapeutic Modality, Natural Killer Cells
i own shares of bexcome. It has been working quite well, especially over the last couple of months. And and so a it stor t come back of amerator. Very good. Let's go ahead and end with another stock. Am f a t e is the ticker symbol on this one. They don't have a drug on the market yet, but they are progressing a through clinical trials. This therapy is a cat that has huge potential. i do want to make clear that i also own shares of Bexcome.
Transcript
Play full episode
